2024-04-012025-03-312025-03-31false10699625Medico Aesthetics Limited2025-11-2786900falseiso4217:GBPxbrli:pure106996252024-03-31106996252025-03-31106996252024-04-012025-03-31106996252023-03-31106996252024-03-31106996252023-04-012024-03-3110699625bus:SmallEntities2024-04-012025-03-3110699625bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3110699625bus:FullAccounts2024-04-012025-03-3110699625bus:PrivateLimitedCompanyLtd2024-04-012025-03-3110699625core:WithinOneYear2025-03-3110699625core:AfterOneYear2025-03-3110699625core:WithinOneYear2024-03-3110699625core:AfterOneYear2024-03-3110699625core:ShareCapital2025-03-3110699625core:SharePremium2025-03-3110699625core:RevaluationReserve2025-03-3110699625core:OtherReservesSubtotal2025-03-3110699625core:RetainedEarningsAccumulatedLosses2025-03-3110699625core:ShareCapital2024-03-3110699625core:SharePremium2024-03-3110699625core:RevaluationReserve2024-03-3110699625core:OtherReservesSubtotal2024-03-3110699625core:RetainedEarningsAccumulatedLosses2024-03-3110699625core:LandBuildings2025-03-3110699625core:PlantMachinery2025-03-3110699625core:Vehicles2025-03-3110699625core:FurnitureFittings2025-03-3110699625core:OfficeEquipment2025-03-3110699625core:NetGoodwill2025-03-3110699625core:IntangibleAssetsOtherThanGoodwill2025-03-3110699625core:ListedExchangeTraded2025-03-3110699625core:UnlistedNon-exchangeTraded2025-03-3110699625core:LandBuildings2024-03-3110699625core:PlantMachinery2024-03-3110699625core:Vehicles2024-03-3110699625core:FurnitureFittings2024-03-3110699625core:OfficeEquipment2024-03-3110699625core:NetGoodwill2024-03-3110699625core:IntangibleAssetsOtherThanGoodwill2024-03-3110699625core:ListedExchangeTraded2024-03-3110699625core:UnlistedNon-exchangeTraded2024-03-3110699625core:LandBuildings2024-04-012025-03-3110699625core:PlantMachinery2024-04-012025-03-3110699625core:Vehicles2024-04-012025-03-3110699625core:FurnitureFittings2024-04-012025-03-3110699625core:OfficeEquipment2024-04-012025-03-3110699625core:NetGoodwill2024-04-012025-03-3110699625core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3110699625core:ListedExchangeTraded2024-04-012025-03-3110699625core:UnlistedNon-exchangeTraded2024-04-012025-03-3110699625core:MoreThanFiveYears2024-04-012025-03-3110699625core:Non-currentFinancialInstruments2025-03-3110699625core:Non-currentFinancialInstruments2024-03-3110699625dpl:CostSales2024-04-012025-03-3110699625dpl:DistributionCosts2024-04-012025-03-3110699625core:LandBuildings2024-04-012025-03-3110699625core:PlantMachinery2024-04-012025-03-3110699625core:Vehicles2024-04-012025-03-3110699625core:FurnitureFittings2024-04-012025-03-3110699625core:OfficeEquipment2024-04-012025-03-3110699625dpl:AdministrativeExpenses2024-04-012025-03-3110699625core:NetGoodwill2024-04-012025-03-3110699625core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3110699625dpl:GroupUndertakings2024-04-012025-03-3110699625dpl:ParticipatingInterests2024-04-012025-03-3110699625dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3110699625core:ListedExchangeTraded2024-04-012025-03-3110699625dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3110699625core:UnlistedNon-exchangeTraded2024-04-012025-03-3110699625dpl:CostSales2023-04-012024-03-3110699625dpl:DistributionCosts2023-04-012024-03-3110699625core:LandBuildings2023-04-012024-03-3110699625core:PlantMachinery2023-04-012024-03-3110699625core:Vehicles2023-04-012024-03-3110699625core:FurnitureFittings2023-04-012024-03-3110699625core:OfficeEquipment2023-04-012024-03-3110699625dpl:AdministrativeExpenses2023-04-012024-03-3110699625core:NetGoodwill2023-04-012024-03-3110699625core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3110699625dpl:GroupUndertakings2023-04-012024-03-3110699625dpl:ParticipatingInterests2023-04-012024-03-3110699625dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3110699625core:ListedExchangeTraded2023-04-012024-03-3110699625dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3110699625core:UnlistedNon-exchangeTraded2023-04-012024-03-3110699625core:NetGoodwill2025-03-3110699625core:IntangibleAssetsOtherThanGoodwill2025-03-3110699625core:LandBuildings2025-03-3110699625core:PlantMachinery2025-03-3110699625core:Vehicles2025-03-3110699625core:FurnitureFittings2025-03-3110699625core:OfficeEquipment2025-03-3110699625core:AfterOneYear2025-03-3110699625core:WithinOneYear2025-03-3110699625core:ListedExchangeTraded2025-03-3110699625core:UnlistedNon-exchangeTraded2025-03-3110699625core:ShareCapital2025-03-3110699625core:SharePremium2025-03-3110699625core:RevaluationReserve2025-03-3110699625core:OtherReservesSubtotal2025-03-3110699625core:RetainedEarningsAccumulatedLosses2025-03-3110699625core:NetGoodwill2024-03-3110699625core:IntangibleAssetsOtherThanGoodwill2024-03-3110699625core:LandBuildings2024-03-3110699625core:PlantMachinery2024-03-3110699625core:Vehicles2024-03-3110699625core:FurnitureFittings2024-03-3110699625core:OfficeEquipment2024-03-3110699625core:AfterOneYear2024-03-3110699625core:WithinOneYear2024-03-3110699625core:ListedExchangeTraded2024-03-3110699625core:UnlistedNon-exchangeTraded2024-03-3110699625core:ShareCapital2024-03-3110699625core:SharePremium2024-03-3110699625core:RevaluationReserve2024-03-3110699625core:OtherReservesSubtotal2024-03-3110699625core:RetainedEarningsAccumulatedLosses2024-03-3110699625core:NetGoodwill2023-03-3110699625core:IntangibleAssetsOtherThanGoodwill2023-03-3110699625core:LandBuildings2023-03-3110699625core:PlantMachinery2023-03-3110699625core:Vehicles2023-03-3110699625core:FurnitureFittings2023-03-3110699625core:OfficeEquipment2023-03-3110699625core:AfterOneYear2023-03-3110699625core:WithinOneYear2023-03-3110699625core:ListedExchangeTraded2023-03-3110699625core:UnlistedNon-exchangeTraded2023-03-3110699625core:ShareCapital2023-03-3110699625core:SharePremium2023-03-3110699625core:RevaluationReserve2023-03-3110699625core:OtherReservesSubtotal2023-03-3110699625core:RetainedEarningsAccumulatedLosses2023-03-3110699625core:AfterOneYear2024-04-012025-03-3110699625core:WithinOneYear2024-04-012025-03-3110699625core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3110699625core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3110699625core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3110699625core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3110699625core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3110699625core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3110699625core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3110699625core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3110699625core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3110699625core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3110699625core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3110699625core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3110699625core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3110699625core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3110699625core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3110699625core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3110699625core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3110699625core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3110699625core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3110699625core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3110699625core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3110699625core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3110699625core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3110699625core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3110699625core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3110699625core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3110699625core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3110699625bus:Director12024-04-012025-03-3110699625bus:Director22024-04-012025-03-31106996251bus:Director22024-03-31106996251bus:Director22024-04-012025-03-31106996251bus:Director22025-03-31106996252024-03-31106996252024-04-012025-03-31106996252025-03-31

Medico Aesthetics Limited

Registered Number
10699625
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

Medico Aesthetics Limited
Company Information
for the year from 1 April 2024 to 31 March 2025

Director

Miss J Aston-Steadman

Registered Address

Bushy Ruff
Sparkwell
Plymouth
PL7 5DD

Registered Number

10699625 (England and Wales)
Medico Aesthetics Limited
Statement of Financial Position
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets322,83720,461
22,83720,461
Current assets
Stocks41,5001,400
Debtors58,1413,685
Cash at bank and on hand3,0761,174
12,7176,259
Creditors amounts falling due within one year6(6,477)(4,713)
Net current assets (liabilities)6,2401,546
Total assets less current liabilities29,07722,007
Creditors amounts falling due after one year7(4,638)(5,749)
Provisions for liabilities8(4,339)-
Net assets20,10016,258
Capital and reserves
Called up share capital100100
Revaluation reserve20,00020,000
Profit and loss account-(3,842)
Shareholders' funds20,10016,258
The financial statements were approved and authorised for issue by the Director on 27 November 2025, and are signed on its behalf by:
Miss J Aston-Steadman
Director
Registered Company No. 10699625
Medico Aesthetics Limited
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and with the Companies Act 2006.
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
Functional and presentation currency
The financial statements are prepared in sterling, which is the functional currency of the entity.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. The taxation expense represents the current tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible fixed assets and depreciation
Tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss. Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life. If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.

Reducing balance (%)Straight line (years)
Plant and machinery2010
Stocks and work in progress
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
2.Average number of employees

20252024
Average number of employees during the year00
3.Tangible fixed assets

Plant & machinery

Total

££
Cost or valuation
At 01 April 2421,53721,537
Additions3,5493,549
At 31 March 2525,08625,086
Depreciation and impairment
At 01 April 241,0761,076
Charge for year1,1731,173
At 31 March 252,2492,249
Net book value
At 31 March 2522,83722,837
At 31 March 2420,46120,461
4.Stocks

2025

2024

££
Finished goods1,5001,400
Total1,5001,400
5.Debtors: amounts due within one year

2025

2024

££
Other debtors8,1413,685
Total8,1413,685
6.Creditors: amounts due within one year

2025

2024

££
Bank borrowings and overdrafts1,1251,125
Taxation and social security3,316-
Accrued liabilities and deferred income2,0363,588
Total6,4774,713
7.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts4,6385,749
Total4,6385,749
8.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)4,339-
Total4,339-
9.Directors advances, credits and guarantees

Brought forward

Amount advanced

Amount repaid

Carried forward

££££
Miss J Aston1,04330,10023,0028,141
1,04330,10023,0028,141